To evaluate the in vivo safety and efficacy of an oral care formulation in terms of Teeth Whitening effect on healthy male and female subjects
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 33
- 试验地点
- 1
研究概览
简要总结
OBJECTIVE:The objective of this study is to evaluate the in-vivo safety & efficacy of an oral care formulation in terms of Teeth Whitening effect on healthy male and female subjects. The evaluation will be performed using: Subject Self Evaluation, Dentist Evaluation: Product Acceptability, Dentist Evaluation: Efficacy , Illustrative Images of Teeth (For 5 Subjects)
POPULATION: 33 male & female subjects will be selected in a ratio of 1:1. The subjects selected for this study will be aged between 18 to 45 years males & females, having natural teeth that are sufficiently discoloured to demonstrate a measurable change.
STUDY DURATION: 1 days following the first application of the product.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- Participant and Outcome Assessor Blinded
入排标准
- 年龄范围
- 18.00 Year(s) 至 45.00 Year(s)(—)
- 性别
- All
入选标准
- •1.Indian / Asian male and female subjects 2.Healthy subjects 3.Having habit of consuming hot/cold/sweet/beverages 4.Smokers and non-smokers may be included; smoking status will be recorded in CRF.
- •Natural teeth that are sufficiently discoloured to demonstrate a measurable change 6.Dehydration may make the teeth appear whiter than the actual shade.
- •Make sure the subject’s teeth are not too dry.
- •7.Shade selection should be made quickly and accept first decision.
- •Eyes usually tire after 5 – 7 seconds.
- •8.Avoid bright colours in the environment.
- •Lipstick, make up, tinted eyeglasses, jewellry, bright-coloured clothes must be removed from the subject and the evaluator.
排除标准
- •For Females: Being pregnant or breastfeeding or having stopped breastfeeding in the past three months.
- •Having refused to give his/her assent by not signing the consent form 3)Taking part in another study liable to interfere with this study 4)Being allergic to use of powder, removal cream/ spray on study site.
- •Being insulin-dependent diabetic or non insulin-dependent diabetic with a recent therapy (less than 6 months) 6)Having a progressive asthma (either under treatment or last fit in the last 2 years) 7)Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area (except for specific studies on a determined dermatosis) 8)Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months) 9)Being epileptic.
- •Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol).
- •Having cutaneous hypersensitivity.
- •Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products.
- •Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months.
- •Having changed cosmetic habits except those required by the protocol in the 14 days preceding the start of the study on the studied anatomic unit.
研究者
Dr Spriha Singh
MASCOT-SPINCONTROL India Pvt. Ltd.
